Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial

INTRODUCTION: Vidofludimus calcium has shown anti-inflammatory effects in clinical trials of autoimmune diseases and recently demonstrated antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We performed a double-blind, randomized, placebo-controlled, phase 2 tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Vehreschild, Maria J. G. T., Atanasov, Petar, Yurko, Kateryna, Oancea, Cristian, Popov, Georgi, Smesnoi, Valentina, Placinta, Gheorghe, Kohlhof, Hella, Vitt, Daniel, Peelen, Evelyn, Mihajlović, Jelena, Muehler, Andreas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568890/
https://www.ncbi.nlm.nih.gov/pubmed/36242741
http://dx.doi.org/10.1007/s40121-022-00690-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568890/
https://www.ncbi.nlm.nih.gov/pubmed/36242741
http://dx.doi.org/10.1007/s40121-022-00690-0

Ejemplares similares